- Home
- SSII vs BCRX Comparison
SSII vs BCRX Comparison
Compare SSII & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSII
- BCRX
- Stock Information
- Founded
- SSII N/A
- BCRX 1986
- Country
- SSII India
- BCRX United States
- Employees
- SSII N/A
- BCRX N/A
- Industry
- SSII
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SSII
- BCRX Health Care
- Exchange
- SSII Nasdaq
- BCRX Nasdaq
- Market Cap
- SSII 1.4B
- BCRX 1.4B
- IPO Year
- SSII N/A
- BCRX 1994
- Fundamental
- Price
- SSII $7.40
- BCRX $6.94
- Analyst Decision
- SSII
- BCRX Strong Buy
- Analyst Count
- SSII 0
- BCRX 11
- Target Price
- SSII N/A
- BCRX $19.00
- AVG Volume (30 Days)
- SSII 156.2K
- BCRX 7.8M
- Earning Date
- SSII 10-28-2025
- BCRX 11-03-2025
- Dividend Yield
- SSII N/A
- BCRX N/A
- EPS Growth
- SSII N/A
- BCRX N/A
- EPS
- SSII N/A
- BCRX N/A
- Revenue
- SSII $36,066,457.00
- BCRX $599,816,000.00
- Revenue This Year
- SSII N/A
- BCRX $41.57
- Revenue Next Year
- SSII N/A
- BCRX $6.25
- P/E Ratio
- SSII N/A
- BCRX N/A
- Revenue Growth
- SSII 158.36
- BCRX 45.38
- 52 Week Low
- SSII $2.48
- BCRX $6.00
- 52 Week High
- SSII $22.42
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- SSII 44.25
- BCRX 44.08
- Support Level
- SSII $7.25
- BCRX $6.51
- Resistance Level
- SSII $10.00
- BCRX $7.22
- Average True Range (ATR)
- SSII 0.65
- BCRX 0.28
- MACD
- SSII -0.27
- BCRX 0.02
- Stochastic Oscillator
- SSII 7.27
- BCRX 43.23
About SSII SS Innovations International Inc.
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.